Suzette Glasner-Edwards

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up
    Suzette Glasner-Edwards
    UCLA Integrated Substance Abuse Programs, UCLA, Los Angeles, California, USA
    J Nerv Ment Dis 197:225-31. 2009
  2. doi request reprint Risk factors for suicide attempts in methamphetamine-dependent patients
    Suzette Glasner-Edwards
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90024, USA
    Am J Addict 17:24-7. 2008
  3. doi request reprint Clinical course and outcomes of methamphetamine-dependent adults with psychosis
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA 90024, USA
    J Subst Abuse Treat 35:445-50. 2008
  4. doi request reprint Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, University of California, Los Angeles, California 90025, USA
    Am J Addict 17:99-102. 2008
  5. pmc Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90024, USA
    Eat Disord 19:259-69. 2011
  6. pmc Psychopathology in methamphetamine-dependent adults 3 years after treatment
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, Semel Institute for Neuroscience and Human Behavior, 1640 S Sepulveda Blvd, Los Angeles, CA 90024, USA
    Drug Alcohol Rev 29:12-20. 2010
  7. pmc Evidence-based practices in addiction treatment: review and recommendations for public policy
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, Semel Institute for Neuroscience and Human Behavior, 1640 S Sepulveda Blvd, Los Angeles, CA 90024, USA
    Health Policy 97:93-104. 2010
  8. pmc Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning
    Suzette Glasner-Edwards
    UCLA Integrated Substance Abuse Programs, Los Angeles, California
    Am J Addict 19:385-90. 2010
  9. doi request reprint Health conditions in methamphetamine-dependent adults 3 years after treatment
    Larissa J Mooney
    From the UCLA Integrated Substance Abuse Programs L J M, S G E, P M C, M H, J H, W L, R R, Los Angeles, CA University of California School of Medicine A A, Los Angeles, CA and University of Hawaii School of Medicine W H, P C, Honolulu, HI
    J Addict Med 3:155-63. 2009
  10. pmc Response: innovations and implementation
    Mardell Gavriel
    Addict Sci Clin Pract 4:47-9. 2008

Detail Information

Publications11

  1. pmc Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up
    Suzette Glasner-Edwards
    UCLA Integrated Substance Abuse Programs, UCLA, Los Angeles, California, USA
    J Nerv Ment Dis 197:225-31. 2009
    ..The findings highlight the relationship of depressive symptoms and diagnoses to treatment outcomes, and suggest a need for further studies of depression in populations using MA...
  2. doi request reprint Risk factors for suicide attempts in methamphetamine-dependent patients
    Suzette Glasner-Edwards
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90024, USA
    Am J Addict 17:24-7. 2008
    ..Psychiatric characteristics of MA users are strongly associated with SA, warranting careful assessment of psychiatric history...
  3. doi request reprint Clinical course and outcomes of methamphetamine-dependent adults with psychosis
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA 90024, USA
    J Subst Abuse Treat 35:445-50. 2008
    ..MA users with co-occurring psychotic illness may therefore benefit from early psychosocial and/or pharmacologic interventions to address psychiatric symptoms...
  4. doi request reprint Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, University of California, Los Angeles, California 90025, USA
    Am J Addict 17:99-102. 2008
    ..These risk factors identify methamphetamine users who may benefit from early interventions for psychiatric symptoms...
  5. pmc Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90024, USA
    Eat Disord 19:259-69. 2011
    ..Addressing MA use among adults with eating disorders may be helpful as a means of improving treatment outcomes...
  6. pmc Psychopathology in methamphetamine-dependent adults 3 years after treatment
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, Semel Institute for Neuroscience and Human Behavior, 1640 S Sepulveda Blvd, Los Angeles, CA 90024, USA
    Drug Alcohol Rev 29:12-20. 2010
    ..We predicted that psychiatric diagnoses and severity would be associated with substance use and poorer overall functioning over the 3 year post-treatment course...
  7. pmc Evidence-based practices in addiction treatment: review and recommendations for public policy
    Suzette Glasner-Edwards
    Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, Semel Institute for Neuroscience and Human Behavior, 1640 S Sepulveda Blvd, Los Angeles, CA 90024, USA
    Health Policy 97:93-104. 2010
    ..Organizational and workforce barriers to EBP implementation are delineated, with corresponding recommendations to facilitate successful dissemination of evidence-based skills...
  8. pmc Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning
    Suzette Glasner-Edwards
    UCLA Integrated Substance Abuse Programs, Los Angeles, California
    Am J Addict 19:385-90. 2010
    ..Addressing anxiety symptoms and syndromes in MA users may be helpful as a means of optimizing treatment outcomes...
  9. doi request reprint Health conditions in methamphetamine-dependent adults 3 years after treatment
    Larissa J Mooney
    From the UCLA Integrated Substance Abuse Programs L J M, S G E, P M C, M H, J H, W L, R R, Los Angeles, CA University of California School of Medicine A A, Los Angeles, CA and University of Hawaii School of Medicine W H, P C, Honolulu, HI
    J Addict Med 3:155-63. 2009
    ....
  10. pmc Response: innovations and implementation
    Mardell Gavriel
    Addict Sci Clin Pract 4:47-9. 2008
  11. ncbi request reprint Mechanisms of action in integrated cognitive-behavioral treatment versus twelve-step facilitation for substance-dependent adults with comorbid major depression
    Suzette Glasner-Edwards
    Veterans Affairs San Diego Healthcare System and University of California, San Diego, 3350 La Jolla Village Drive, San Diego, California 92161 2002, USA
    J Stud Alcohol Drugs 68:663-72. 2007
    ....